Unlike GLP-1, supraphysiologic GIP infusions do not amplify the late phase insulin response to glucose in patients with T2DM ( Native GLP-1 and GIP have limited pharmacologic value because of their short plasma half-life (17 min) ( Leveraging the Incretin Effect for the Treatment of T2DM Because of the apparent lack of beta-cell responsiveness to GIP in patients with poorly controlled T2DM, most therapeutic strategies have focused on enhancing the activity of GLP-1
Dermatologists are using them off-label to combat a variety of skin conditions, including rosacea and psoriasis
Neuroscientist and podcaster Andrew Huberman has described them as a new kind of wedge in between supplements and prescription pills. GQ called them the hottest thing on the fringes of fitness and anti-aging.Many are looking to peptides, a confusingly wide-ranging group of compounds, for a fitness and longevity edge
Sharma RK, Vittetoe KL, Barna AJ, et al
Peptidet er naturlig forekommende i kroppen, noe som betyr at biologiske systemer kjenner og tolererer det godt